<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Elliott Advisors (UK) Limited 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=34195></link><description><![CDATA[Elliott Advisors (UK) Limited 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Tue, 05 May 2026 06:21:58 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2019/12/12_3554238800_20191210095621_7765642202.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Paper Source to Be Acquired by Elliott]]></title><link>https://www.newswire.co.kr/newsRead.php?no=923210</link><description><![CDATA[CHICAGO & NEW YORK & LONDON--(Business Wire/Korea Newswire)--Elliott Investment Management L.P. (“Elliott”) announces today that funds it advises have entered into a definitive agreement to acquire the assets and business operations of Paper Source Inc.  The acquisition of Paper Source by Elliott allows the stationery and gift retailer to emerge from Chapter 11 with the support of a well-capitalized owner...]]></description><pubDate>Wed, 12 May 2021 11:50:00 +0900</pubDate></item><item><title><![CDATA[Elliott Statement on SoftBank]]></title><link>https://www.newswire.co.kr/newsRead.php?no=902508</link><description><![CDATA[LONDON & TOKYO--(Business Wire/Korea Newswire)--SoftBank’s announcement of its intention to commence an initial buyback program of 500 billion yen is clearly an important first step in addressing the Company’s significant undervaluation, and one that Elliott supports. Elliott believes that SoftBank will have opportunities to pursue additional buybacks following the completion of the Sprint/T-...]]></description><pubDate>Mon, 16 Mar 2020 09:14:37 +0900</pubDate></item><item><title><![CDATA[Elliott Statement on Alexion]]></title><link>https://www.newswire.co.kr/newsRead.php?no=898594</link><description><![CDATA[LONDON--(Business Wire/Korea Newswire)--Funds advised by Elliott Advisors (UK) Limited (together “Elliott” or “we”) acknowledge the statement issued by Alexion Pharmaceuticals, Inc. (“Alexion” or “the Company”) on Friday.  Elliott confirms that it has had a multiyear, constructive and private engagement with Alexion that has led to value-creative changes at the Company. Despite two ye...]]></description><pubDate>Tue, 10 Dec 2019 09:59:33 +0900</pubDate></item></channel></rss>